The store will not work correctly when cookies are disabled.
5-Aziridin-1-yl-2-hydroxymethyl-3,6-dimethyl-1H-indole-4,7-dione
ID: ALA342473
PubChem CID: 9813608
Max Phase: Preclinical
Molecular Formula: C13H14N2O3
Molecular Weight: 246.27
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC1=C(N2CC2)C(=O)c2c([nH]c(CO)c2C)C1=O
Standard InChI: InChI=1S/C13H14N2O3/c1-6-8(5-16)14-10-9(6)13(18)11(15-3-4-15)7(2)12(10)17/h14,16H,3-5H2,1-2H3
Standard InChI Key: ARVYALYBJUWXGA-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
6.2750 -6.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2750 -6.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2375 -6.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2375 -6.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7500 -5.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8417 -6.9000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7500 -7.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7167 -5.8125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8417 -5.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2000 -6.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4125 -5.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1167 -5.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7500 -5.2125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7500 -7.6125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7167 -7.0125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8000 -6.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0292 -5.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1000 -5.8917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 5 1 0
4 3 2 0
5 1 1 0
6 2 1 0
7 2 1 0
8 3 1 0
9 1 1 0
10 9 2 0
11 8 1 0
12 8 1 0
13 5 2 0
14 7 2 0
15 4 1 0
16 10 1 0
17 9 1 0
18 16 1 0
10 6 1 0
4 7 1 0
11 12 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 246.27 | Molecular Weight (Monoisotopic): 246.1004 | AlogP: 0.78 | #Rotatable Bonds: 2 |
Polar Surface Area: 73.17 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.24 | CX Basic pKa: ┄ | CX LogP: 0.04 | CX LogD: 0.04 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.76 | Np Likeness Score: 0.57 |
References
1. Xing C, Wu P, Skibo EB, Dorr RT.. (2000) Design of cancer-specific antitumor agents based on aziridinylcyclopent[b]indoloquinones., 43 (3): [PMID:10669573] [10.1021/jm990466w] |